XU ZHENYU (Chief Scientific Officer) sold 1.3% of their position (8.12K shares) of SOPHIA GENETICS SA on the open market
Open‑market sale worth $38.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/14/2026ACC: 0001840706-26-000151
Officer· Chief Scientific Officer
Since Mar 2026
-8.12K
Net shares
Net seller
$38.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
8.12K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−3.71K
Price / share
$4.68
Trade value
$17.35K
% of position
0.6%
4/10/2026
640.22K→636.51K
Ordinary Shares
Direct
Shares
−1.01K
Price / share
$4.76
Trade value
$4.83K
% of position
0.2%
4/13/2026
636.51K→635.50K
Ordinary Shares
Direct
Shares
−3.40K
Price / share
$4.76
Trade value
$16.20K
% of position
0.5%
4/13/2026
635.50K→632.10K
Total
Net shares
−8.12K
Net value
-$38.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/10/2026 | S · Sale | −3.71K | $4.68 | $17.35K | 0.6% | 640.22K | 636.51K |
| Ordinary Shares Direct | 4/13/2026 | S · Sale | −1.01K | $4.76 | $4.83K | 0.2% | 636.51K | 635.50K |
| Ordinary Shares Direct | 4/13/2026 | S · Sale | −3.40K | $4.76 | $16.20K | 0.5% | 635.50K | 632.10K |
| Total | −8.12K | -$38.37K | ||||||
Derivative Transactions0
No derivative transactions reported